Citation: W. Feleszko et al., RE - GRAYING OF AMERICA WILL FOSTER NEW STRATEGIES IN ONCOLOGY, Journal of the National Cancer Institute, 90(3), 1998, pp. 247-248
Authors:
GOLAB J
STOKLOSA T
ZAGOZDZON R
KACA A
KULCHITSKA LA
FELESZKO W
KAWIAK J
HOSER G
GLOWACKA E
DABROWSKA A
GIERMASZ A
LASEK W
JAKOBISIAK M
Citation: J. Golab et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR POTENTIATES ANTITUMOR-ACTIVITY OF INTERLEUKIN-12 IN MELANOMA MODEL IN MICE, Tumor biology, 19(2), 1998, pp. 77-87
Authors:
FELESZKO W
ZAGOZDZON R
GOLAB J
JAKOBISIAK M
Citation: W. Feleszko et al., POTENTIATED ANTITUMOR EFFECTS OF CISPLATIN AND LOVASTATIN AGAINST MMB16 MELANOMA IN MICE, European journal of cancer, 34(3), 1998, pp. 406-411
Authors:
GOLAB J
STOKLOSA T
ZAGOZDZON R
KACA A
GIERMASZ A
POJDA Z
MACHAJ E
DABROWSKA A
FELESZKO W
LASEK W
IWANOSIECKA A
JAKOBISIAK M
Citation: J. Golab et al., G-CSF PREVENTS THE SUPPRESSION OF BONE-MARROW HEMATOPOIESIS INDUCED BY IL-12 AND AUGMENTS ITS ANTITUMOR-ACTIVITY IN A MELANOMA MODEL IN MICE, Annals of oncology, 9(1), 1998, pp. 63-69
Authors:
GOLAB J
ZAGOZDZON R
STOKLOSA T
KACA A
DABROWSKA A
GIERMASZ A
FELESZKO W
JAKOBISIAK M
Citation: J. Golab et al., GRANULOCYTE-COLONY-STIMULATING FACTOR DEMONSTRATES ANTITUMOR-ACTIVITYIN MELANOMA MODEL IN MICE, Neoplasma, 45(1), 1998, pp. 35-39
Authors:
NOWICKA D
ZAGOZDZON R
MAJEWSKI S
MARCZAK M
BOLLAG W
JABLONSKA S
Citation: D. Nowicka et al., ENHANCEMENT OF ANTIANGIOGENIC AND ANTINEOPLASTIC ACTIVITY OF IL-12 BYTHE COMBINATION WITH CALCITRIOL, Journal of investigative dermatology, 110(4), 1998, pp. 523-523
Authors:
ZAGOZDZON R
GOLAB J
STOKLOSA T
GIERMASZ A
NOWICKA D
FELESZKO W
LASEK W
JAKOBISIAK M
Citation: R. Zagozdzon et al., EFFECTIVE CHEMOIMMUNOTHERAPY OF L1210 LEUKEMIA IN-VIVO USING INTERLEUKIN-12 COMBINED WITH DOXORUBICIN BUT NOT WITH CYCLOPHOSPHAMIDE, PACLITAXEL OR CISPLATIN, International journal of cancer, 77(5), 1998, pp. 720-727
Authors:
GOLAB J
ZAGOZDZON R
STOKLOSA T
LASEK W
JAKOBISIAK M
POJDA Z
MACHAJ E
Citation: J. Golab et al., ERYTHROPOIETIN PREVENTS THE DEVELOPMENT OF INTERLEUKIN-12-INDUCED ANEMIA AND THROMBOCYTOPENIA BUT DOES NOT DECREASE ITS ANTITUMOR-ACTIVITY IN MICE, Blood, 91(11), 1998, pp. 4387-4388
Authors:
WOJCIK C
STOKLOSA T
GIERMASZ A
GOLAB J
ZAGOZDZON R
KAWIAK J
WILK S
KOMAR A
KACA A
MALEJCZYK J
JAKOBISIAK M
Citation: C. Wojcik et al., APOPTOSIS INDUCED IN L1210 LEUKEMIA-CELLS BY AN INHIBITOR OF THE CHYMOTRYPSIN-LIKE ACTIVITY OF THE PROTEASOME, Apoptosis, 2(5), 1997, pp. 455-462
Authors:
ZAGOZDZON R
STOKLOSA T
GOLAB J
GIERMASZ A
DABROWSKA A
LASEK W
JAKOBISIAK M
Citation: R. Zagozdzon et al., AUGMENTED ANTITUMOR EFFECTS OF COMBINATION THERAPY WITH INTERLEUKIN-12, CISPLATIN, AND TUMOR-NECROSIS-FACTOR-ALPHA IN A MURINE MELANOMA MODEL, Anticancer research, 17(6D), 1997, pp. 4493-4498
Authors:
MAJEWSKI S
NOWICKA D
ZAGOZDZON R
MARCZAK M
BOLLAG W
JABLONSKA S
Citation: S. Majewski et al., ENHANCEMENT OF ANTITUMOR AND ANTIANGIOGENIC ACTIVITY OF INTERLEUKIN-12 (IL-12) BY CALCITRIOL AND 9-CIS RETINOIC ACID, Journal of investigative dermatology, 109(3), 1997, pp. 436-436
Authors:
LASEK W
GIERMASZ A
KUC K
WANKOWICZ A
FELESZKO W
GOLAB J
ZAGOZDZON R
STOKLOSA T
JAKOBISIAK M
Citation: W. Lasek et al., POTENTIATION OF THE ANTITUMOR EFFECT OF ACTINOMYCIN-D BY TUMOR-NECROSIS-FACTOR-ALPHA IN MICE - CORRELATION BETWEEN IN-VITRO AND IN-VIVO RESULTS, International journal of cancer, 66(3), 1996, pp. 374-379